NCT03406871 2025-01-24
REGONIVO
National Cancer Center Hospital East
Phase 1 Completed
Clinical Trials
4 trialsNCT01896856 2020-10-06
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT02168777 2018-01-26
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
Bayer
Phase 1 Terminated
NCT01117623 2015-11-18
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies
Bayer
Phase 1 Completed